The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
28 - I would like to run a print DTC advertizing campaign. The content will be limited to the brand name and a sentence along the line of 'ask your doctor'. No claims will be made. The media used is not targeting any specific audience. I would like to know: if the text has to be submitted if the text on the actual support has to be submitted which articles of the code I should refer to
DTCA/I, consumer secondary audience
1
Posts
1
Posters
294
Views
1
Watching
-
DTCRx ads are not subject to mandatory review within the requirements of the PAAB Code of Advertising Acceptance. If the sponsor requests it, PAAB will give an opinion on DTCRx ads based on the Health Canada policy document "The Distinction Between Advertising and Other Activities". The opinion service is endorsed by Health Canada and Innovative Medicines Canada. If you choose to send a DTCRx project for PAAB opinion we would require seeing the layout, graphics and words to be used.
